Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology ...